Category: 3. Business

  • Sanjeev Gupta readies last-ditch plan to save specialty arm of Liberty Steel | Steel industry

    Sanjeev Gupta readies last-ditch plan to save specialty arm of Liberty Steel | Steel industry

    Sanjeev Gupta is preparing a last-ditch attempt to save the remaining arm of his Liberty Steel business as government officials step up planning for a collapse of the business within days.

    Gupta is understood to have spent the weekend planning an 11th hour rescue deal to save the company’s Speciality Steels UK (SSUK) division days before a courtroom showdown with its creditors on Wednesday.

    The metals magnate hopes to secure a pre-pack administration deal that would allow the company to ditch its debts and other liabilities before being bought back by Gupta or parties connected to him.

    The plan is likely to raise eyebrows in Whitehall where government officials are reportedly planning for a collapse of the heavily indebted steel division, while fraud investigations into other areas of Gupta’s business empire remain open.

    A Liberty Steel spokesperson said discussions are ongoing to finalise options for SSUK that “best serve the interests of creditors, employees and the broader community”.

    The restructuring specialist Begbies Traynor is working on the pre-pack deal, according to Sky News, which first reported the plans, but any deal would need Liberty Steel’s creditors, including the British tax authority HM Revenue and Customs (HMRC) and Swiss lender UBS, to agree to write off potentially hundreds of millions of pounds of debt.

    Gupta has limited time to finalise any attempt to rescue his subsidiary before an expected court hearing on Wednesday relating to a winding-up petition, that was issued by a supplier over unpaid debts.

    Government officials have reportedly stepped up planning for the collapse of SSUK if the winding-up petition is approved this week, according to Sky. The hearing, which has already been deferred several times, could force SSUK into compulsory liquidation, leaving a court-appointed official receiver to run the business.

    SSUK is the UK’s third-largest steel producer and employs nearly 1,500 people. The South Yorkshire-based business includes an electric arc furnace at Rotherham, plus steelworks in Stocksbridge, near Sheffield, making steel for the car industry, as well as for use in construction and engineering.

    Financial pressure has been mounting on Gupta’s metals and energy companies stretching from Australia through Singapore and Romania to northern England, known as the GFG Alliance.

    The group has been in trouble since the 2021 failure of Greensill Capital, which collapsed after lending GFG about $5bn (£3.7bn). Gupta has been engaged in long-running talks with the administrators of Greensill, who are trying to recover the money.

    GFG has been under investigation by the UK’s Serious Fraud Office since 2021 in relation to the Greensill financing. The company and Gupta have denied any wrongdoing.

    Gupta is also being prosecuted by Companies House over the failure to file accounts for more than 70 UK businesses – including those of Liberty Pipes, based in Hartlepool. He has pleaded not guilty.

    Some industry figures have said they expect the government to step in to ensure the plants keep running if they fall into liquidation – although it is not thought that the government will give financial support to Gupta’s companies.

    A spokesperson at the Department for Business said: “We continue to closely monitor developments around Liberty Steel, including any public hearings, which are a matter for the company.”

    Continued financial pressures on Gupta’s companies have followed years of difficulty for the wider UK steel industry. British steel production fell to its lowest level since the 1930s in 2024, and the government in effect took over the British Steel blast furnaces at Scunthorpe in April, amid fears of more than 2,700 job losses and the end of primary steel-making in the UK.

    Continue Reading

  • Bitcoin Just Hit $124,000. Is $150,000 Next?

    Bitcoin Just Hit $124,000. Is $150,000 Next?

    Bitcoin is once again surging. But for how long?

    On Aug. 14, Bitcoin (BTC 0.18%) surged to a new all-time high above $124,000. The world’s most popular cryptocurrency is now up nearly 30% for the year and appears poised for further gains, based on improving market sentiment for crypto.

    But can Bitcoin soar even higher, to $150,000? To answer that question, it’s important to consider what’s powering it.

    Catalysts for Bitcoin

    There are several different catalysts pushing Bitcoin higher right now. One of them, of course, is the recent executive order from the White House that will open the door for crypto to be included in 401(k) plans. This is expected to unlock trillions of dollars in new capital, a big chunk of which will likely flow into Bitcoin.

    Another key factor is institutional adoption. Simply put, everyone seems to be buying Bitcoin these days. Corporations are buying Bitcoin. Bitcoin treasury companies are buying Bitcoin. And the U.S. government continues to suggest that it will find a “budget-neutral” way to buy Bitcoin. 

    Image source: Getty Images.

    At the same time, money continues to flow into spot Bitcoin ETFs. This is arguably the best way to track institutional demand. If inflows into spot Bitcoin ETFs are positive, it means Bitcoin is likely to glide still higher. If inflows dry up, Bitcoin could be in for a rocky ride.

    Finally, there’s the overall macroeconomic situation.​​ The broader market seems to be coming to grips with tariffs and what they likely will mean for the U.S. economy. For now, inflationary pressures do not seem as threatening as they were back in April, and investors are now expecting a series of interest rate cuts starting in September. Historically, lower rates have been favorable for crypto and have led to more money moving into risky, volatile assets such as Bitcoin.

    So everything is trending in Bitcoin’s favor. A combination of institutional adoption, improving market sentiment, and expectations of rate cuts are juicing the market and helping to push Bitcoin higher.

    What do prediction markets think?

    That said, Bitcoin is hardly a lock to hit $150,000 this year. One way to get a sense of what the overall market thinks is by looking at data from prediction markets. There, people are trading contracts based on where they think the price of Bitcoin is going next.

    On the Kalshi prediction market, for example, traders think Bitcoin has a 75% chance of hitting $130,000 this year, a 53% chance of hitting $140,000, and a 37% chance of hitting $150,000. So, basically, there’s a 1-in-3 chance that Bitcoin will hit $150,000 by the end of the year.

    Things get a bit dicier from there. For example, there is only a 27% chance that Bitcoin will hit $160,000 and a 10% chance that Bitcoin will hit $200,000. This last data point is particularly noteworthy because, at the start of the year, just about everyone was predicting that Bitcoin would double in value and easily hit $200,000.

    What to look for next

    The market is pricing in an interest rate cut, but that can’t happen if inflation rears its ugly head. And that’s exactly what happened almost as soon as Bitcoin hit $124,000. New economic data suggested that inflationary pressures were building. As a result, Bitcoin quickly slid back down to $120,000.

    With that in mind, Bitcoin investors should keep a close eye on any and all economic data that the Federal Reserve might take into account when deciding how to adjust interest rates in September. Notably, this marks a departure from the way people invested in Bitcoin in the past. Historically, money has flowed into Bitcoin regardless of what people think the Fed might (or might not) be doing.

    Just a few years ago, Bitcoin was completely uncorrelated with any major asset class. And that meant Bitcoin could zig when other assets zagged. But we’re starting to see a correlation with stocks, and especially tech stocks. With institutional investors lining up for a piece of Bitcoin, the world’s most popular cryptocurrency is starting to behave more and more like a risky, high-upside tech stock.

    Long-term, I’m still bullish on Bitcoin. But as we saw back in April, when Bitcoin buckled under the threat of tariffs, it remains a highly volatile digital asset subject to the broader macroeconomic outlook. There’s a reasonably good chance Bitcoin will hit $150,000, but only if the broader economy doesn’t deteriorate.

    Continue Reading

  • Assessments of children who may have had unnecessary hip surgeries pushed back to next year – The Irish Times

    Assessments of children who may have had unnecessary hip surgeries pushed back to next year – The Irish Times

    Children who may have been subjected to unnecessary hip dysplasia surgery must wait until next year before they are assessed by a team of external experts for a second medical opinion.

    In May, the HSE published an independent audit on hip surgery thresholds for children with developmental dysplasia of the hip.

    It examined 147 cases across three hospitals: Temple Street, the National Orthopaedic Hospital Cappagh and Crumlin Hospital. In Temple Street, 60 per cent of surgeries audited did not meet the clinical threshold for surgical intervention, while this was the case for 79 per cent in the Cappagh hospital.

    Following the report, the HSE announced it was commissioning an independent expert review panel that will work to review patient files to determine the appropriateness of the original decision to operate.

    The HSE said then that the review panel would be set up within six months. However, a spokeswoman for the executive has now said it will be January before the review of individual cases begins.

    The health service issued an international call for experts, with applications accepted up until last Friday.

    “Expressions of interest have been received from a wide range of regions including Ireland, the UK, the USA, Canada, Asia and other parts of Europe,” the spokeswoman said.

    “These submissions will be subject to a shortlisting and recruitment process prior to the formal announcement of the panel, which is expected to convene in September.”

    She said an international expert has been identified and agreed to chair the external panel, and terms are being negotiated.

    The organisation is designing a “robust scientific and methodological framework” for the review, which is expected to be agreed between September and December this year.

    “It is expected that the review of individual cases will commence in January. This timeline reflects the complexity of the work involved and the need to ensure a rigorous and comprehensive approach,” it added.

    The HSE, Children’s Health Ireland (CHI) and patient advocates held a meeting on the external review panel last Thursday.

    In a statement following the meeting, Hip Dysplasia Advocacy Group, a newly-established representative organisation, said there must be “full transparency” between the HSE and the families regarding these reviews. It said “everyone is left completely in the dark”.

    “We strongly suggested they set up a webpage to inform families of updates in a timely manner and we hope to see this implemented swiftly,” the statement said.

    The advocacy group described the engagement with CHI at the meeting as positive, adding that the paediatric healthcare provider anticipates all follow-up appointments for affected children will be completed by the end of the year.

    Continue Reading

  • Bitcoin Price Watch: Consolidation Phase Could Precede Sharp Rally—or Breakdown – Bitcoin.com News

    Bitcoin Price Watch: Consolidation Phase Could Precede Sharp Rally—or Breakdown – Bitcoin.com News

    1. Bitcoin Price Watch: Consolidation Phase Could Precede Sharp Rally—or Breakdown  Bitcoin.com News
    2. Bitcoin hits fresh record as Fed easing bets add to tailwinds  Reuters
    3. China’s exports face pressure due to external uncertainties, firms face more difficulties  investingLive
    4. This Week in Crypto: Bitcoin to All-Time High, ETH Leads Altcoins, XRP Escrow Debacle  BeInCrypto
    5. The Critical Moment for Bitcoin Acquisition Driven by Institutional Demand  OneSafe

    Continue Reading

  • Julie Churchill, DVM, PhD, DACVIM (Nutrition)

    Julie Churchill, DVM, PhD, DACVIM (Nutrition)

    Sponsored by Blue Buffalo Company

    A professor of nutrition at the University of Minnesota College of Veterinary Medicine in St Paul, Julie Churchill, DVM, PhD, DACVIM (Nutrition), teaches veterinary students at all stages, from first year to final rotations. “I have the luckiest job in the world,” she said. “I have the perfect mix of about 50% of my time is in the classroom and approximately 50% of my time is in the clinic. So I get to see patients, I get to work with clients, and I get to work with house officers in the clinical settings, so residents and interns as well as colleagues.”

    Julie Churchill, DVM, PhD, DAVIM, is the 2025 Veterinary Heroes honoree in the nutrition category, sponsored by Blue Buffalo Company.

    As a specialist in nutrition, Churchill does work that extends well beyond healthy food and preparing diet plans. It includes comorbidities and complex cases that do not always have a clearly identifiable dietary plan to help manage conditions. Her patients range from puppies and kittens to older animals. “I see such a variety [of patient cases], so it is never a dull moment,” Churchill said. “We do a nutrition assessment for every patient in [the] ICU [intensive care unit], so I have a great passion for critical care and our hospitalized patients. And I get to work with our primary care [team], so I get to see healthy [pets] too.”

    Churchill is a volunteer for the Association for Pet Obesity Prevention and works with the organization to find ways to help health care teams prevent and treat obesity and educate pet owners about weight management. She was also invited by the American Animal Hospital Association to participate in a task force addressing the organization’s weight management guidelines.

    “The goal was how can we develop tools to make weight management easier for the health care team….Nutrition is a team sport,” Churchill said.

    She urged veterinary professionals to not shy away from conversations about obesity. “Pet parents are craving these conversations. Veterinarians and veterinary teams are still the most trusted source,” she said. “We not only care for the pets throughout life, but we build this lovely, loyal clientele. We build clients for life by having those conversations and being there for their pet at every stage of life.”

    The 2025 class of dvm360 Veterinary Heroes will be honored at a celebratory luncheon at the Fetch dvm360 Conference in Kansas City, Missouri. Click here to learn more or register for the event.

    Continue Reading

  • Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.59% – Investing.com

    1. Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.59%  Investing.com
    2. Saudi slips on weaker corporate earnings; Egypt hits new record high  Reuters
    3. Closing Bell: TASI closes at 10,791 with active trading of $1.24bn  Arab News PK
    4. The Saudi stock market index closed lower despite strong liquidity  المتداول العربي
    5. The Saudi stock market closes higher and liquidity surpasses 3.2 billion riyals  المتداول العربي

    Continue Reading

  • Gold Prices May See Consolidation Next Week As Focus Shifts To Fed, US Data

    Gold Prices May See Consolidation Next Week As Focus Shifts To Fed, US Data

    Modi also stated that physical gold demand in Asia, usually a seasonal driver, remained subdued due to elevated prices.

    Investors are turning their focus on preliminary US PMI data and Fed Chair Powell’s upcoming speech at the Jackson Hole Symposium and the broader trajectory of Washington-Moscow discussions, he added.

    Overall, the near-term outlook for gold will hinge on how incoming data and central bank commentary shape market sentiment, analysts said.

    Continue Reading

  • Unleashing the biological potential of marine algal extracts against Staphylococcus aureus isolated from ready-to-eat beef products

    Unleashing the biological potential of marine algal extracts against Staphylococcus aureus isolated from ready-to-eat beef products

    Ready-to-eat (RTE) food is becoming increasingly popular among restaurants and street sellers worldwide, including in Egypt. Although RTE products offer the convenience of fast food, they also represent a risk of bacterial infection as they are not heated further. S. aureus cross-contamination of meat products is a leading cause of food poisoning globally37. The current research explored the ubiquitous distribution of S. aureus in the analyzed RTE beef products. In the current study, 30.7% of RTE-tested samples were positive for S. aureus. Similar findings were reported previously in Shaanxi Province, China (34.4%)37 and Libya (32%)38. In comparison, the obtained results are higher than those documented by other foodborne illness studies on RTE beef products that were 11.8% in China39 and 23.4% in Zagazig city, Egypt40. Otherwise, this result was lower than stated in beef products at Qalubeya Governorate, Egypt (50.8%)41.

    Certain restaurant staff members need to gain awareness of and adhere to hygienic protocols, particularly personal hygiene-related ones; others may partially or fully observe these protocols. The fact is that the majority of workers don’t wear aprons, gloves, or protective head covers. Rather, some employees eat, drink, and even smoke while they work. According to recent studies, luncheon samples eaten immediately without being heated had lower S. aureus levels than those (kofta, burger, and shawarma) previously39. In contrast, our results highlighted that the highest incidence of S. aureus among RTE beef products was in luncheon samples by 36.7% with a mean of 6.1 × 10 ± 0.4 × 10 CFU/g. This confirms inadequate sanitary practices at the time of luncheon preparation and processing.

    Moreover, Food handlers may be responsible for contaminated meat with S. aureus due to cross-contamination from their hands42. Our results agreed well with those of other studies in Egypt41,43. Furthermore, Morshdy et al.43 declared that S. aureus was more prevalent in Egypt’s kofta (90%), luncheon (50%), burger (75%), and shawarma (80%). These variations in meat microbiological quality can be attributed to factors such as cooking method (frying, roasting, or grilling), raw ingredient quality, meat size and shape, cooking utensils (stew container, grill, oven), and seasoning (dressings, vegetables, herbs, spices)44.

    The high frequency of S. aureus in beef products may be because certain employees follow hygiene procedures inside these restaurants, wiping down contact surfaces that are exposed to food, like tables, preparation boards, and utensils, using just a towel or some soap and water. On rare occasions, some continue to work while experiencing hand or respiratory problems like boils or coughing. Humans experience a wide range of diseases as a result of these conditions. Therefore, enhancing processing methods, monthly checks of workers and utensils for S. aureus, frequent disinfection of food contact surfaces, proper heating of beef products, and finally, strict personnel hygiene measures are all important to prevent the existence of S. aureus in RTE beef products42.

    The current study declared that 58.7% of the S. aureus isolates from the samples that were looked at had coagulase, 47.6% had nuc, and 13% had only seb amongst other S.E.s encoding genes. More than 13% of S. aureus confined from RTE beef products were affirmative for more than one virulence-associated gene (Table 2). Amplification of the coagulase gene proved to be a rapid and precise approach for typing S. aureus. All explored isolates of S. aureus produce the coagulase gene, a highly virulent component. Coagulase results in plasma coagulation in the host and is an identifying marker for S. aureus infection45. The existence of coagulase and nuc genes explored in this study is comparable with previous studies 45,46.

    Additionally, S.E.s are the most prominent virulence genes in S. aureus and the leading cause of staphylococcal food poisoning. The weak evidence of staphylococcal food poisoning outbreaks with the classical enterotoxins seb, sec, sed, and she can be identified commercially47. Although the Egyptian Organization for Specification and Quality Control48 requires that S.E.s not be detected in beef products, our study detected the seb gene in 13% of isolated S. aureus, which produces enterotoxins. In addition, Sallam et al. 49 identified sea, seb, and sec genes in all positive isolates. Wu et al.5 concluded that all S. aureus isolates had a minimum of one enterotoxin gene.

    The incidence of S.E. genes in a wide range of isolates underlines their vertical transmission potential rather than horizontal transmission, as most of these genes exist in mobile parts of the genome. S. aureus enterotoxin explored gene differs by country due to geographical variations and is further influenced by the isolated strains’ ecological sources (food, animals, and humans). Moreover, in Poland, sec; Bulgaria, sea; and Egypt, seb are the most common toxin genes 46,50,51. The isolates’ toxin gene profiles vary according to their origin, isolation samples, and geographical location.

    On the other hand, resistance to penicillin, cefoxitin, and oxacillin was significantly detected in the S. aureus isolates in this study. This finding aligns with Wu et al.5 and Abbasi et al.52, who documented an increase in β-Lactam resistance among S. aureus isolates. Also, strong resistance to aminoglycoside antibiotics was reported in previous studies, except Abbasi et al.52, who reported lower resistance to kanamycin, tetracycline, and Chloramphenicol. Moreover, Komodromos et al.53 reported similar penicillin resistance and lower Sulfamethoxazole/Trimethoprim, ampicillin, cefoxitin, tetracycline, and chloramphenicol resistance. The study found that 50% of the isolates resisted cefoxitin and were considered MRSA. This study has also revealed that shawarma had the highest occurrence of MRSA isolates, accounting for 55.5% of the samples. Following closely behind were Kofta, burger, and Sausage, each with a frequency of 50%. In contrast to the global meta-analysis, which reported a detection rate of 3.2% for MRSA in beef products, the current study reveals a significantly higher prevalence of this bacterium54. The rate of MRSA isolation observed in this study also exceeds that reported by Mahros et al.42 and Song et al. 55. However, the frequency was lower than reported by Saber et al.40.

    In the current study, 15 out of 23 MRSA investigated were positive for the mecA gene, and 8 out of 23 MRSA did not show any presence of the mecA gene. These alternative mec genes, such as mecB or mecC, could be responsible for their methicillin resistance. According to Yang et al.39 and Abbasi et al.52, the prevalence of mecA was found in 6 and 32 MRSA strains, while Saber et al. 40 and Al-Amery et al. 56 amplified mecA in all MRSA strains. Furthermore, Vancomycin is the optimal therapeutic option for treating methicillin-resistant biofilm infections57. However, the World Health Organization has categorized vancomycin-resistant S. aureus (VRSA) as a “high priority” antibiotic-resistant pathogen due to its significant impact on public health. The percentage of VRSA found in our samples was higher than that found by Yang et al.39 and Al-Amery et al.56 in previously published studies. Notably, none of the isolates obtained by Wang et al.37 and Abbasi et al.52 exhibited vancomycin resistance. The varying levels of antimicrobial resistance observed across various studies may be attributed to the differences in opinions among veterinary physicians about which type of antimicrobial agents should be prescribed, the practicality of regulations that limit their use, and the pricing of such agents. These factors can significantly impact the prevalence of antimicrobial resistance within distinct geographical regions.

    Eleven distinct antimicrobial resistance profiles and 39 MDR isolates were revealed. The MDR isolates observed in our study exhibit higher levels when compared to the findings reported by Velasco et al.58, and Ou et al.59. Such variations in resistance profiles can have significant implications for the treatment and control of infections caused by this bacterium. The antimicrobial susceptibility evaluation has yielded results indicating a notable occurrence of resistance towards specific antimicrobials, with a range of resistance patterns identified among the isolates of S. aureus60. This can be attributed primarily to the extensive and inconsistent utilization of these agents, particularly in veterinary medicine, resulting in a significant increase in the prevalence of antimicrobial resistance. Moreover, the excessive application of disinfectants, self-treatment with antimicrobial agents, and the provision of single-dose therapies have all contributed to this issue. Hence, it is crucial to promptly adopt rigorous preventive strategies to restrict the transmission of antimicrobial resistance across all stages of food production60.

    Biofilm formation was a common characteristic among most strains of S. aureus. Our findings are consistent with previous research, highlighting the ability of S. aureus isolates from meat and meat products to form biofilms52,53. The production of biofilms by S. aureus and their simultaneous presence with saprophytic microorganisms within these biofilms undeniably gives rise to the establishment of persistent contamination reservoirs within food-processing facilities44. These findings are supported by Ou et al.59, as they revealed that food serves as an excellent adhesive medium and a reservoir for S. aureus because the common properties among food substrates, particularly their viscosity, play an overwhelmingly significant role in the successful colonization of S. aureus as compared to the differences in food surface properties and bacterial species.

    The role of the ica genes in forming biofilms by S. aureus strains has been extensively explored. It has been consistently observed that the majority of biofilm-producing S. aureus strains in the current study possess the icaA and icaD genes either separately or in combination, with the icaD being predominant, which disagrees with the study of Saber et al.40 where the icaA was the most prevalent demonstrates a significant correlation with the formation of biofilms. The results obtained in this study align with Tang et al.61, who found that 87.5% of S. aureus strains isolated from different food sources possessed the icaA and icaD genes. This indicates a consistent presence of these genes in S. aureus strains across various origins. Furthermore, Abbasi et al.52 detected icaA and icaD genes in biofilm-producing S. aureus obtained from raw meat and meat products (80.4% each). These findings emphasize the importance of the icaA and icaD genes in forming biofilms by S. aureus, which can affect food safety.

    In this study, isolates containing the icaD gene produced biofilms that ranged from moderate to strong. In contrast, isolates that expressed both icaA and icaD exhibited strong biofilm (p < 0.05). Mubarak and El-Zamkan62 confirmed these results. Contrarily, it has been ascertained that three isolates were identified to have solely the icaA gene and were linked with a weak biofilm phenotype. A study conducted by Gerke et al.63 explained the link between genotype and phenotype. They found that icaA alone had a weak N-acetylglucosaminyl transferase activity, but when icaD was co-transcribed with icaA, it had full activity. Biofilm is one of the useful tools used by S. aureus to resist antibiotics59, which illustrates the significant relationship between biofilm formation and MDR in this study.

    The study’s findings are quite alarming as they reveal that a significant number of MRSA strains (60.9%) are also VRSA, a major cause of concern. Moreover, 21.7% of these strains have developed resistance against both vancomycin and Linezolid. These results highlight the need for urgent action to address the escalating concern of antibiotic resistance and to find new ways to combat these pathogens. Also, this study reveals that all MRSA are MDR and biofilm producers, except three isolates, non-biofilm producers, while 14 out of 18 VRSA (77.8%) are biofilm producers. S. aureus biofilm-associated infections give rise to severe and potentially fatal diseases, including endocarditis, septic arthritis, cystic fibrosis, and recurrent infections in both human and animal communities64. This finding underscores the significant impact of MRSA as an opportunistic pathogen in nosocomial infections, as it demonstrates high levels of resistance to various antibiotics and possesses a wide range of virulence factors. What adds to the concern is that a considerable proportion of MRSA strains (60.9%) also exhibit resistance to vancomycin, a major cause of concern. Moreover, 35.7% of MRSA and VRSA strains resist Linezolid, which is crucial in MRSA treatment. Another problem is that 4 MRSA/VRSA isolates harbored the seb gene. Identifying beef products as a reservoir for virulence and antibiotic-resistant S. aureus highlights the pressing need for prompt intervention. These findings emphasize the urgency of taking action to mitigate the issue of antibiotic resistance and to discover alternative methods for combating these organisms.

    The 32.6% MRSA confirmation rate in ready-to-eat meat products represents a significant public health threat, particularly for vulnerable populations including hospitalized patients, immunocompromised individuals, and elderly consumers. The presence of virulent MRSA strains carrying both resistance (mecA) and virulence (nuc) genes in commonly consumed foods highlights the urgent need for integrated surveillance and control measures spanning the entire food-to-healthcare continuum9,11.

    Protecting human health from the harmful consequences of hostile S. aureus has become increasingly challenging. The chemical preservatives’ destructive effects on human health, microbial resistance, toxicity, susceptibility, and their limited application have upsurged the demand for potentially effective, safer, healthy, and natural antimicrobial agents with a unique force against pathogens, especially S. aureus12. Thus, the antibacterial activity of algal extracts can provide a crucial component of S. aureus infection remedy that traditional antibacterial agents cannot. In addition, they can be used as organic preservatives to safeguard healthier and safer food away from the risks and harmful side effects of ordinary chemical preservatives12. In the current study, three algal species (crude extracts), including H. opuntia, J. rubens, and C. racemosa, exerted strong bactericidal activity, dose-dependently, against S. aureus according to seaweed species and used solvent. Persuasive antibacterial activity was recognized for C. racemosa in methanol extract against S. aureus, resulting in a reduction of serious bacterial growth (Δabs 620) at a 1.5 mg/ml concentration. However, the concentrations of 1.5 mg/ml of J. rubens (ethyl acetate extract) and H. opuntia (acetone extract) showed much less bacterial growth reduction (Δabs 620) in S. aureus (Fig. 7).

    Diverse studies explored the antibacterial potential activities of marine seaweed, viz., J. rubens, H. opuntia, and C. racemosa. Different solvents, viz., petroleum ether, acetone, chloroform, methanol, ethyl acetate, ethanol, hexane, and water, were practiced for algae extraction to explore the antimicrobial algal extract activity against bacterial cultures, including S. aureus12,65. C. racemosa (methanol extract) exhibits the strongest activity against the growth of MRSA (methicillin-resistant S. aureus) with the highest antimicrobial effect (97.7 ± 0.30%)58. Similar results were obtained by Chan et al.66, using the broth microdilution technique, where methanolic, hexane, acetone, chloroform, ethyl acetate, and ethanolic extracts of C. racemosa showed different activity against Gram-positive bacteria growth (S. aureus) with a 0.36 mm inhibition zone.

    Furthermore, the C. racemosa extract exhibits a dual mechanism of action against S. aureus, combining direct bactericidal effects with targeted virulence suppression. The profound inhibition of nuc and coa genes detected by RT-PCR analysis suggests the extract disrupts both immune evasion (via nuclease suppression) and clotting mechanisms (via coagulase reduction). While the log reduction demonstrates killing capacity, the virulence gene suppression occurs even at sub-lethal concentrations, potentially reducing selective pressure for resistance. This combined approach—simultaneously decreasing pathogen load and disabling virulence factors—may prove more effective than conventional antibiotics. Future studies should identify the active compounds responsible for these effects and evaluate their efficacy in animal infection models.

    Moreover, it was reported that C. racemosa exhibited promising antimicrobial activity against human and food pathogens67,68. The promising efficacy of the marine seaweed C. racemosa extract against the S. aureus pathogen could be due to the active metabolites, phytochemicals, and fatty acids as well as their derivatives65,66. The promising antibacterial effects of methanol extract of C. racemosa against S. aureus could be peculiarities to the most bountiful detected phytochemicals and bioactive compounds including spathulenol (1.29%), Cubenol (0.45%), 2-Cyclohexen-1-one, 2-methyl-5-(1-methylethenyl) (0.41%), trans-calamenene (0.3%).

    Additionally, in vitro data in previous literature showed that Spathulenol poses potent antimicrobial activities against diverse bacterial cultures, including S. aureus67. It has been declared that spathulenol has a major role in anti-inflammatory, immunomodulatory, and antiproliferative activities, with non-toxic, non-mutagenic, and non-tumorigenic properties, and could be a potential antimicrobial drug69. Moreover, Cubenol and 2-Cyclohexen showed antibacterial activities against S. aureus with MICs ranging from 7.81  to 15.62 mg/ml. Moreover, a promising antifungal activity against filamentous fungi was detected, which could be utilized in wide-ranging applications to prevent microbial growth as drug molecules, cosmetics, and food 70.

    It is reasonable to assume that the detected compounds have potential antibacterial features and that extracts of the algae in which they are abundant have powerful antibiotic properties. The investigated algae species may be more efficient against pathogenic bacteria than typical bactericidal treatments. Hence, they may be regarded as natural preservatives, delivering nutritious and safe food through their stable, biologically active molecules without the adverse effects of chemicals. It also offers perspectives on discovering innovative antibacterial agents for food preservation or therapeutic applications.

    The observed antimicrobial activity of the algal extracts can be attributed to the presence of bioactive constituents, which have been previously reported for their antibacterial properties. For instance, spathulenol has demonstrated significant antimicrobial effects71, while cubenol has been shown to inhibit bacterial growth72. Similarly, 2-cyclohexen-1-one, 2-methyl-5-(1-methylethenyl)73 and trans-calamenene74 have also been documented for their antibacterial activities. These compounds likely contribute to the overall antimicrobial efficacy of the algal extracts by targeting bacterial cell membranes, disrupting enzymatic functions, or inducing oxidative stress. The presence of such bioactive constituents in the algal extracts underscores their potential as natural antimicrobial agents.

    Continue Reading

  • The new ChatGPT has some AI fans rethinking when to expect ‘superintelligence’ – The Washington Post

    1. The new ChatGPT has some AI fans rethinking when to expect ‘superintelligence’  The Washington Post
    2. Women with AI ‘boyfriends’ mourn lost love after ‘cold’ ChatGPT upgrade  Al Jazeera
    3. Did the system update ruin your boyfriend? Love in a time of ChatGPT | Arwa Mahdawi  The Guardian
    4. Is AI hitting a wall?  Financial Times
    5. The latest ChatGPT is supposed to be ‘PhD level’ smart. It can’t even label a map  CNN

    Continue Reading

  • This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he’d do it again

    This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he’d do it again

    Eric Vaughan, CEO of enterprise-software powerhouse IgniteTech, is unwavering as he reflects on the most radical decision of his decades-long career. In early 2023, convinced that generative AI was an “existential” transformation, Vaughan looked at his team and saw a workforce not fully on board. His ultimate response: He ripped the company down to the studs, replacing nearly 80% of staff within a year, according to headcount figures reviewed by Fortune.

    Over the course of 2023 and into the first quarter of 2024, Vaughan said IgniteTech replaced hundreds of employees, declining to disclose a specific number. “That was not our goal,” he told Fortune. “It was extremely difficult … But changing minds was harder than adding skills.” It was, by any measure, a brutal reckoning—but Vaughan insists it was necessary, and says he’d do it again.

    For Vaughan, the writing on the wall was clear and dramatic. “In early 2023, we saw the light,” he told Fortune in an interview, adding that he believed every tech company was facing a crucial inflection point around adoption of artificial intelligence. “Now I’ve certainly morphed to believe that this is every company, and I mean that literally every company, is facing an existential threat by this transformation.”

    Where others saw promise, Vaughan saw urgency—believing that failing to get ahead on AI could doom even the most robust business. He called an all-hands meeting with his global, remote team. Gone were the comfortable routines and quarterly goals. Instead, his message was direct: Everything would now revolve around AI. “We’re going to give a gift to each of you. And that gift is tremendous investment of time, tools, education, projects … to give you a new skill,” he explained. The company began reimbursing for AI tools and prompt engineering classes, and even brought in outside experts to evangelize.

    “Every single Monday was called ‘AI Monday,’” Vaughan said, with his mandate for staff that they could only work on AI. “You couldn’t have customer calls, you couldn’t work on budgets, you had to only work on AI projects.” He said this happened across the board, not just for tech workers, but also for sales, marketing, and everybody at IgniteTech. “That culture needed to be built. That was… that was the key.”

    This was a major investment, he added: 20% of payroll was dedicated to a mass-learning initiative, and it failed because of mass resistance, even sabotage. Belief, Vaughan discovered, is a hard thing to manufacture. “In those early days, we did get resistance, we got flat-out, ‘Yeah, I’m not going to do this’ resistance. And so we said goodbye to those people.”

    The pushback: Why didn’t they get on board?

    Vaughan was surprised to find it was often the technical staff, not marketing or sales, who dug in their heels. They were the “most resistant,” he said, voicing various concerns about what the AI couldn’t do, rather than focusing on what it could. The marketing and salespeople were enthused by the possibilities of working with these new tools, he added.

    This friction is borne out by broader research. According to the 2025 enterprise AI adoption report by WRITER, an AI platform that specifically helps enterprise clients with AI integration, one in three workers say they’ve “actively sabotaged” their company’s AI rollout—a number that jumps to 41% of millennial and Gen Z employees. This can take the form of refusing to use AI tools, intentionally generating low-quality outputs, or avoiding training altogether. Many act out due to fears that AI will replace their jobs, while others are frustrated by lackluster AI tools or unclear strategy from leadership.

    WRITER’s Chief Strategy Officer Kevin Chung told Fortune the “big eye-opening thing” from this survey was the human element of AI resistance. “This sabotage isn’t because they’re afraid of the technology … It’s more like there’s so much pressure to get it right, and then when you’re handed something that doesn’t work, you get frustrated.” He added that WRITER’s research shows that workers often don’t trust where their organizations are headed. “When you’re handed something that isn’t quite what you want, it’s very frustrating, so the sabotage kicks in, because then people are like, ‘Okay, I’m going to run my own thing. I’m going to go figure it out myself.’” You definitely don’t want this kind of “shadow IT” in an organization, he added.

    Vaughan says he didn’t want to force anyone. “You can’t compel people to change, especially if they don’t believe.” He added that belief was really the thing he needed to recruit for. Company leadership ultimately realized they’d have to launch a massive recruiting effort for what became known as “AI Innovation Specialists.” This applied across the board, to sales, finance. marketing, everywhere. Vaughan said this time was “really difficult” as things inside the company were “upside down … We didn’t really quite know where we were or who we were yet.”

    A couple key hires helped, starting with the person who became IgniteTech’s chief AI officer, Thibault Bridel-Bertomeu. That led to a full reorganization of the company that Vaughan called “somewhat unusual.” Essentially, every division now reports into the AI organization, regardless of domain.

    This centralization, Vaughan says, prevented duplication of efforts and maximized knowledge sharing—a common struggle in AI adoption, where WRITER’s survey shows 71% of the C-suite at other companies say AI applications are being created in silos and nearly half report their employees left to “figure generative AI out on their own.”

    No pain, no gain?

    In exchange for this difficult transformation, IgniteTech reaped extraordinary results. By the end of 2024, the company had launched two patent-pending AI solutions, including a platform for AI-based email automation (Eloquens AI), with a radically rebuilt team.

    Financially, IgniteTech remained strong. Vaughan disclosed that the company, which he said is in the nine-figure revenue range, finished 2024 at “near 75% EBITDA”—all while completing a major acquisition, Khoros. “You multiply people … give people the ability to multiply themselves and do things at a pace,” he said, touting the company’s ability to build new customer-ready products in as little as four days—an unthinkable timeline in the old regime.

    What does Vaughan’s story say for others? On one level, it’s a case study in the pain and payoff of radical change management. But his ruthless approach arguably addresses many challenges identified in the WRITER survey: lack of strategy and investment, misalignment between IT and business, and the failure to engage champions who can unlock AI’s benefits.

    The ‘boy who cried wolf’ problem

    To be sure, IgniteTech is far from alone in wrestling with these challenges. Joshua Wöhle is the CEO of Mindstone, a firm similar to WRITER that provides AI upskilling services to workforces, training hundreds of employees monthly at companies including Lufthansa, Hyatt, and NBA teams. He recently discussed the two approaches described by Vaughan—upskilling and mass replacement—in an appearance on BBC Business Today.

    Wöhle contrasted the recent examples of Ikea and Klarna, arguing the former’s example shows why it’s better to “reskill” existing employees. Klarna, a Swedish buy-now pay-later firm, drew considerable publicity for a decision to reduce members of its customer support staff in a pivot to AI, only to rehire for the same roles. “We’re near the point where [AI is] more intelligent than most people doing knowledge work. But that’s precisely why augmentation beats automation,” Wöhle wrote on LinkedIn.

    A representative for Klarna told Fortune the company did not lay off employees, but has instead adopted several approaches to its customer service, which is managed by outsourced customer-service providers who are paid according to the volume of work required. The launch of an AI customer-service assistant reduced the workload by the equivalent of 700 full-time agents—from roughly 3,000 to 2,300—and the third-party providers redeployed those 700 workers to other clients, according to Klarna. Now that the AI customer service agent is “handling more complex queries than when we launched,” Klarna says, that number has fallen to 2,200. Klarna says its contractor has rehired just two people in a pilot program designed to combine highly trained human support staff with AI to deliver outstanding customer service. 

    In an interview with Fortune, Wöhle said one client of his has been very blunt with his workers, ordering them to dedicate all Fridays to AI retraining, and if they didn’t report back on any of their work, they were invited to leave the company. He said it can be “kinder” to dismiss workers who are resistant to AI: “The pace of change is so fast that it’s the kinder thing to force people through it.” He added that he used to think that if he got all workers to really love learning, then that could help Mindstone make a real difference, but he discovered after training literally thousands of people that “most people hate learning. They’d avoid it if they can.”

    Wöhle attributed much of the AI resistance in the workforce to a “boy who cried wolf” problem from the tech sector, citing NFTs and blockchain as technologies that were billed as revolutionary but “didn’t have the real effect” that tech leaders promised. “You can’t really blame them” for resisting, he said. Most people “get stuck because they think from their work flow first,” he added, and they conclude AI is overhyped because they want AI to fit into their old way of working. “It takes a lot more thinking and a lot more kind of prodding for you to change the way that you work,” but once you do, you see dramatic increases. A human can’t possibly keep five call transcripts in their head while you’re trying to write a proposal to a client, he offers, but AI can.

    Ikea echoed Wöhle when reached for comment, saying that its “people-first AI approach focuses on augmentation, not automation.” A spokesperson said Ikea is using AI to automate tasks, not jobs, freeing up time for value-added, human-centric work.

    The WRITER report notes that companies with formal AI strategies are far more likely to succeed, and those who heavily invest in AI outperform their peers by a large margin. But, as Vaughan’s experience shows, investment without belief and buy-in can be wasted energy. “The culture needed to be built. Ultimately, we ended up having to go out and recruit and hire people that were already of the same mind. Changing minds was harder than adding skills.”

    For Vaughan, there’s no ambiguity. Would he do it again? He doesn’t hesitate: He’d rather endure months of pain and build a new, AI-driven foundation from scratch than let an organization drift into irrelevance. “This is not a tech change. It is a cultural change, and it is a business change.” He said he doesn’t recommend that others follow his lead and swap out 80% of their staff. “I do not recommend that at all. That was not our goal. It was extremely difficult.” But at the end of the day, he added, everybody’s got to be in the same boat, rowing in the same direction. Otherwise, “we don’t get where we’re going.”

    Continue Reading